Nav: Home

Magnetic surgical cement heals spinal fractures, provides targeted drug delivery

July 27, 2018

Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement. While kyphoplasty can stabilize the bone, cancer patients are still often left with spinal column tumors that are very hard to reach with conventional chemotherapy, which has to cross the blood-brain barrier when delivered intravenously.

Now, researchers at the University of Illinois at Chicago report in the journal PLOS ONE, that by adding magnetic particles to surgical cement used to heal spinal fractures, they could guide magnetic nanoparticles directly to lesions near the fractures. Nanoparticles bound to various drugs have been used to target drugs to specific locations or types of cells in the body. Most commonly, this is achieved by binding a minute amount of drug to the nanoparticle, which is designed to also bind to a specific type of cell, such as a cancer cell.

"By modifying the kyphoplasty bone cement, we can both stabilize the spinal column and provide a targeted drug delivery system. This is a very promising technology as it has the potential to become a surgical option for patients with primary spinal column tumors or tumors that metastasize to the spinal column," said Steven Denyer, a third-year medical student in the UIC College of Medicine and a co-lead author on the paper.

Using a pig model to study the magnetically-guided drug delivery system, Denyer and colleagues were successfully able to steer magnetic nanoparticles to the magnetic cement in the animal's spinal vertebrae. In future studies to test the efficacy of this technique on treating spinal column tumors, the magnetic nanoparticles would be bound to tiny amounts of chemotherapy drugs.

"Our study provides an in vivo proof-of-concept that this novel drug delivery system can help treat underlying causes of spinal fractures in addition to providing structural support," said Abhiraj Bhimani, a fourth-year medical student in the UIC College of Medicine and a co-lead author on the paper.
-end-
Steven Papastefan, Pouyan Kheirkhan, Tania Aguilar, Jack Zakrzewski, Clayton Rosinski, Akash Patel, Saavan Paten, Victoria Zakrzewski, Akop Seksenyan, Gail Prins and Dr. Ankit Mehta from the University of Illinois at Chicago are co-authors on the paper.

Denyer receives research support from the Hispanic Center of Excellence at UIC and Bhimani is a James Scholar student for UIC College of Medicine class of 2019. This work was supported by the department of neurosurgery at the University of Illinois Hospital.

University of Illinois at Chicago

Related Tumors Articles:

Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.
A solid vaccine for liquid tumors
Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years.
Evolutionarily novel genes work in tumors
A team of scientists from Peter the Great St. Petersburg Polytechnic University studied the evolutionary ages of human genes and identified a new class of them expressed in tumors -- tumor specifically expressed, evolutionarily novel (TSEEN) genes.
Identification of all types of germ cells tumors
Germ cell tumors were considered very heterogeneous and diverse, until recently.
Laser light detects tumors
A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light.
Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, deciding a course of treatment can depend on a variety of factors, some of which may seem to contradict one another.
The evolution of brain tumors
Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas.
Why some brain tumors respond to immunotherapy
Fewer than 1 in 10 patients with glioblastoma -- the most common type of brain cancer -- respond to immunotherapy; a new study reveals how to detect patients who may respond.
Heating up cold tumors
A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.
Physics can show us the inside of tumors
A team of physicists from the CNRS and Université Claude Bernard Lyon 1 has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors.
More Tumors News and Tumors Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.